← Back
$AQST All transactions

Aquestive Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$63K

Shares

10,000

Price

$6

Filed

Sep 29

Insider

Name

Boyd Peter E.

Title

See Remarks

CIK

0001739816

Roles

Officer

Transaction Details

Transaction Date

2025-09-26

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

278,323

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Filing Info

Accession No.

0001214659-25-014287

Form Type

4

Issuer CIK

0001398733

Boyd Peter E.'s History

Date Ticker Type Value
2026-03-10 AQST $124K
2026-03-09 AQST A $0
2026-03-09 AQST A $182K
2025-12-04 AQST A $0
2025-10-15 AQST $70K
2025-09-26 AQST $63K
2025-09-05 AQST $80K
2025-03-07 AQST A $0

Other Insiders at AQST (90d)

Insider Bought Sold Last
TOTH A ERNEST JR
Chief Financial Officer
$243K 2026-03-10
TOTH A ERNEST JR
SVP, Chief Financial Officer
2025-03-07
Boyd Peter E.
Chief People Officer
$124K 2026-03-10
Barber Daniel
President and CEO
$754K 2026-03-10
BRAENDER LORI J
Chief Legal Officer
$167K 2026-03-10
BRAENDER LORI J
Corporate Secretary
2025-03-07
Jung Cassie
Chief Operating Officer
$191K 2026-03-10
Korczynski Sherry
Chief Commercial Officer
$66K 2026-03-10
Cioffi Melina
SVP, Regulatory Affairs
$106K 2026-03-10
Davis Matthew W.
Chief Development Officer
2026-03-09
Greenhawt Matthew J.
Chief Medical Officer
2026-03-09